Display options
Share it on

Curr Ther Res Clin Exp. 2012 Dec;73(6):207-19. doi: 10.1016/j.curtheres.2012.08.002.

Analysis of the protective biochemical and pathologic effects of aminoguanidine on an experimental aspiration pneumonitis model induced by bile acids.

Current therapeutic research, clinical and experimental

Rifat Karli, Hasan Alacam, Latif Duran, Omer Alici, Celal Kati, Arzu Karli, Ahmet Guzel

Affiliations

  1. Department of Otorhinolaryngology, Ondokuz Mayis University, Samsun, Turkey.
  2. Department of Medical Biochemistry, Ondokuz Mayis University, Samsun, Turkey.
  3. Department of Emergency Medicine, Ondokuz Mayis University, Samsun, Turkey.
  4. Department of Pathology, Samsun Education and Research Hospital, Samsun, Turkey.
  5. Department of Pediatric Infection, Ondokuz Mayis University, Samsun, Turkey.
  6. Department of Pediatrics, Ondokuz Mayis University, Samsun, Turkey.

PMID: 24653522 PMCID: PMC3955109 DOI: 10.1016/j.curtheres.2012.08.002

Abstract

BACKGROUND: Gastroesophageal reflux (GER) is a common clinical pathology detected in childhood. Bile acids (BAs) are present in reflux and cause various pathologies in the esophagus, the larynx, and the lungs.

OBJECTIVE: We aimed to show if aminoguanidine (AG) contributes to the biochemical and histopathologic treatment of experimental aspiration pneumonitis induced by BAs.

METHODS: Twenty-eight female Sprague Dawley rats were used. There were 4 groups in the study: (1) group aspirated with 0.9% saline (n = 7), (2) group aspirated with 0.9% saline and treated with AG (n = 7), (3) group aspirated with a solution of 10 mg/kg taurocholic acid and 5 mg/kg taurochenodeoxycholate (n = 7), and (4) group aspirated with BA and treated with AG (n = 7). The saline and BA solutions were administered as 1 mL/kg intratracheally. The AG was administered intraperitoneally twice a day at a 150 mg/kg dose for 7 days. The different histopathologic and biochemical parameters were analyzed.

RESULTS: Clara cell protein 16 and malondialdehyde levels were found to be significantly higher in the BA group than in the group where saline was administered; however, they were significantly lower in the BA + AG group than in the BA group. The total superoxide dismutase activity decreased significantly in the BA group compared with the group where saline was administered. A significant increase in superoxide dismutase activity was observed in the BA + AG group when compared with the group where only BA was administered. When the group where BA was administered solely was compared with the group where saline was administered, peribronchial inflammatory cell infiltration, alveolar septal infiltration, alveolar histiocytes, interstitial fibrosis, and granuloma were significantly higher in the BA group than in the saline group. When the BA + AG group was compared with the BA group, peribronchial inflammatory cell infiltration, alveolar septal infiltration, alveolar histiocytes, interstitial fibrosis, and granuloma were found to be significantly lower.

CONCLUSIONS: Oxidant stress increases and antioxidant capacity decreases in pneumonitis induced by BAs. AG administration as an antioxidant helps in recovery, both biochemically and histopathologically. Consequently, AG seems to be an alternative that should be considered in a conservative approach to treating aspiration pneumonitis.

Keywords: CC-16; aminoguanidine; aspiration pneumonitis; bile acids; gastroesophageal reflux

References

  1. ORL J Otorhinolaryngol Relat Spec. 2011;73(3):156-61 - PubMed
  2. Methods Enzymol. 1990;186:421-31 - PubMed
  3. Gastroenterology. 1995 Jun;108(6):1897-907 - PubMed
  4. J Biochem Mol Toxicol. 2004;18(2):69-77 - PubMed
  5. Intensive Care Med. 1987;13(6):395-400 - PubMed
  6. J Thorac Cardiovasc Surg. 2005 May;129(5):1144-52 - PubMed
  7. Am J Respir Cell Mol Biol. 2005 Sep;33(3):231-47 - PubMed
  8. Clin Invest Med. 2008;31(4):E182-8 - PubMed
  9. Expert Rev Mol Diagn. 2010 Apr;10(3):309-19 - PubMed
  10. Int J Pediatr Otorhinolaryngol. 2010 Nov;74(11):1251-3 - PubMed
  11. Anesth Analg. 1989 Jul;69(1):87-92 - PubMed
  12. Neurochem Res. 2011 Mar;36(3):476-86 - PubMed
  13. J Biol Chem. 1951 Nov;193(1):265-75 - PubMed
  14. Can J Surg. 1975 Jan;18(1):64-9 - PubMed
  15. Circulation. 1999 Jul 27;100(4):400-6 - PubMed
  16. Am J Transplant. 2006 Aug;6(8):1930-8 - PubMed
  17. Int J Pediatr Otorhinolaryngol. 2006 Jan;70(1):19-25 - PubMed
  18. J Lab Clin Med. 1967 Jul;70(1):158-69 - PubMed
  19. Int J Pediatr Otorhinolaryngol. 2008 Aug;72(8):1241-50 - PubMed
  20. Gastroenterology. 1996 Nov;111(5):1192-9 - PubMed
  21. J Pediatr Surg. 2008 Jan;43(1):59-63; discussion 63-5 - PubMed
  22. Nutrition. 2003 Jul-Aug;19(7-8):666-9 - PubMed
  23. J Pediatr. 2005 Mar;146(3 Suppl):S3-12 - PubMed
  24. J Dent Res. 2004 Apr;83(4):343-8 - PubMed
  25. Ann Otol Rhinol Laryngol. 2005 Mar;114(3):192-7 - PubMed
  26. Clin Chem. 1988 Mar;34(3):497-500 - PubMed
  27. Clin Chim Acta. 1993 Jan 31;214(1):103-4 - PubMed
  28. Clin Chem. 1990 Aug;36(8 Pt 1):1440-3 - PubMed
  29. Proc Natl Acad Sci U S A. 1989 Aug;86(16):6377-81 - PubMed
  30. J Appl Physiol Respir Environ Exerc Physiol. 1981 Aug;51(2):335-45 - PubMed

Publication Types